Scientific article
Case report
Open access

Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report

Published inBMC Endocrine Disorders, vol. 20, no. 1, 155
Publication date2020

Detailed description of hyperglycemia management in diabetic patients infected with SARS-CoV-2 remain limited, although patients with diabetes show higher complication and mortality rate than patients without diabetes. Transient non-severe increased insulin requirement in patients hospitalized for medical conditions such as sepsis or myocardial infarction is a well-known phenomenon. However, extremely high-dose insulin requirement remains a very rarely reported entity. Here, we report the case of an extreme and transitory insulin requirement episode in a type 2 diabetic patient presenting an acute respiratory distress syndrome caused by SARS-CoV-2.

  • Betacoronavirus/isolation & purification
  • COVID-19
  • Coronavirus Infections/complications/transmission/virology
  • Diabetes Mellitus
  • Type 2/drug therapy/epidemiology/pathology/virology
  • Dose-Response Relationship
  • Drug
  • Humans
  • Hypoglycemic Agents/therapeutic use
  • Insulin/therapeutic use
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia
  • Viral/complications/transmission/virology
  • Prognosis
  • SARS-CoV-2
Citation (ISO format)
JORNAYVAZ, François et al. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report. In: BMC Endocrine Disorders, 2020, vol. 20, n° 1, p. 155. doi: 10.1186/s12902-020-00632-2
Main files (1)
Article (Published version)
ISSN of the journal1472-6823

Technical informations

Creation03/23/2021 11:18:00 AM
First validation03/23/2021 11:18:00 AM
Update time03/16/2023 1:21:14 AM
Status update03/16/2023 1:21:14 AM
Last indexation02/12/2024 12:10:31 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack